Tom 18, Nr 2 (2024)
Inne materiały uzgodnione z Redakcją
Opublikowany online: 2024-04-26
Wyświetlenia strony 61
Wyświetlenia/pobrania artykułu 13
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Parvovirus B19 — skin manifestations and systemic symptoms of infection — case series and proposed diagnostic process flowchart

Raman Nitskovich12, Izabela Staniszewska1, Aleksandra Jóźwik1, Irena Walecka12
Forum Medycyny Rodzinnej 2024;18(2):84-89.

Streszczenie

Parvovirus B19 (PVB19) infections are very common. Up to 60% of the adults’ population is seropositive. This virus has a wide range of clinical presentation in children and in adults. In children, it most often manifests itself as erythema infectiosum. It may be asymptomatic, mildly symptomatic, or fully symptomatic. The most severe PVB19 infections concern primary infection of pregnant women and non-immunocompetent people, leading to hematological complications. We present two case reports of PVB19 infection with skin lesions that provide a closer picture of the skin lesions and symptoms occurring during this infection in adults, and our proposed diagnostic process flowchart for a patient with suspected PVB19 infection.

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. Jacquot R, Gerfaud-Valentin M, Mekki Y, et al. [Parvovirus B19 infections in adults]. Rev Med Interne. 2022; 43(12): 713–726.
  2. Lunardi C, Tinazzi E, Bason C, et al. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev. 2008; 8(2): 116–120.
  3. Peterlana D, Puccetti A, Corrocher R, et al. Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta. 2006; 372(1-2): 14–23.
  4. Kerr JR. Parvovirus B19 infection. European Journal of Clinical Microbiology & Infectious Diseases. 1996; 15(1): 10–29.
  5. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007; 2 Suppl 1(6): S47–S56.
  6. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J. 1987; 6(8): 711–718.
  7. Russcher A, Kroes ACM, Koppelman MH, et al. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants? J Clin Virol. 2016; 84(4): 19–23.
  8. Rodríguez Bandera AI, Mayor Arenal M, Vorlicka K, et al. Acute parvovirus B19 infection in adults: a retrospective study of 49 cases. Actas Dermosifiliogr. 2015; 106(1): 44–50.
  9. Grilli R, Izquierdo MJ, Fariña MC, et al. Papular-purpuric "gloves and socks" syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol. 1999; 41(5 Pt 1): 793–796.
  10. Flunker G, Peters A, Wiersbitzky S, et al. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol. 1998; 186(4): 189–194.
  11. Dittmer FP, Guimarães Cd, Peixoto AB, et al. Parvovirus B19 infection and pregnancy: review of the current knowledge. J Pers Med. 2024; 14(2).
  12. Tolfvenstam T, Broliden K. Parvovirus B19 infection. Semin Fetal Neonatal Med. 2009; 14(4): 218–221.